556 related articles for article (PubMed ID: 28686848)
1. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
2. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
6. Naringin activates semaphorin 3A to ameliorate TGF-β-induced endothelial-to-mesenchymal transition related to atrial fibrillation.
Lai YJ; Chang SH; Tung YC; Chang GJ; Almeida C; Chen WJ; Yeh YH; Tsai FC
J Cell Physiol; 2024 May; 239(5):e31248. PubMed ID: 38501506
[TBL] [Abstract][Full Text] [Related]
7. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
[TBL] [Abstract][Full Text] [Related]
8. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.
Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q
J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.
Cheng W; Li X; Liu D; Cui C; Wang X
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):3-11. PubMed ID: 32851865
[TBL] [Abstract][Full Text] [Related]
10. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
Yin Y; Zhang Q; Zhao Q; Ding G; Wei C; Chang L; Li H; Bei H; Wang H; Liang J; Jia Z
Biomed Res Int; 2019; 2019():6595437. PubMed ID: 31317035
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
Xu X; Tan X; Tampe B; Nyamsuren G; Liu X; Maier LS; Sossalla S; Kalluri R; Zeisberg M; Hasenfuss G; Zeisberg EM
Cardiovasc Res; 2015 Mar; 105(3):279-91. PubMed ID: 25616414
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition.
Xu L; Fu M; Chen D; Han W; Ostrowski MC; Grossfeld P; Gao P; Ye M
BMB Rep; 2019 Oct; 52(10):595-600. PubMed ID: 30670148
[TBL] [Abstract][Full Text] [Related]
13. HMEC-1 adopt the mixed amoeboid-mesenchymal migration type during EndMT.
Kryczka J; Przygodzka P; Bogusz H; Boncela J
Eur J Cell Biol; 2017 Jun; 96(4):289-300. PubMed ID: 28487031
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes.
Yao Y; Song Q; Hu C; Da X; Yu Y; He Z; Xu C; Chen Q; Wang QK
Cardiovasc Res; 2022 Jan; 118(1):196-211. PubMed ID: 33483741
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
Katsura A; Suzuki HI; Ueno T; Mihira H; Yamazaki T; Yasuda T; Watabe T; Mano H; Yamada Y; Miyazono K
Genes Cells; 2016 Jan; 21(1):99-116. PubMed ID: 26663584
[TBL] [Abstract][Full Text] [Related]
17. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
18. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
19. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
Jiang Y; Zhou X; Hu R; Dai A
Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
[TBL] [Abstract][Full Text] [Related]
20. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
